Journal
/
Medicine
/
Vorbereitung und Pathogeninaktivierung von Double Dose Buffy Coat Platelet Produkte, die INTERCEPT Blood System
JoVE Journal
Medicine
This content is Free Access.
JoVE Journal Medicine
Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Please note that all translations are automatically generated. Click here for the English version.

Vorbereitung und Pathogeninaktivierung von Double Dose Buffy Coat Platelet Produkte, die INTERCEPT Blood System

Deutsch

Automatically Generated

28,271 Views

•

12:40 min

•

December 07, 2012

DOI:

10.3791/4414-v

DOI:
10.3791/4414-v

•

12:40 min
December 07, 2012

•

7 Views
,
1Department of Laboratory Medicine, Section for Transfusion Medicine,Örebro University Hospital

Summary

Automatically generated

Dieser Artikel beschreibt den Prozess, durch Örebro University Hospital verwendet werden, um doppelte Dosis Leukozytenfilm Thrombozytenkonzentrate aus Vollblutspenden hergestellt und behandelt mit dem INTERCEPT Blood System für Pathogeninaktivierung produzieren. Die<em> In vitro</em> Qualität der endgültigen Thrombozyten Einheiten sind über 7 Tagen Lagerung ausgewertet.

Explore More Videos

PreparationPathogen InactivationDouble DoseBuffy CoatPlatelet ProductsINTERCEPT Blood SystemBlood CentersProduction YieldSafetyTransfusion Transmitted DiseasesFiscally ResponsibleOperating ExpensesConsumablesEquipmentWastePersonnel CostsPlatelet ConcentratesTherapeutic Platelet UnitBuffy Coat MethodWhole Blood DonationsDouble Dose Whole Blood Derived PlateletsINTERCEPT Processing Set With Dual Storage Containers

Read Article

Cite this Article

Abedi, M. R., Doverud, A. Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System. J. Vis. Exp. (70), e4414, doi:10.3791/4414 (2012).

Download .ris file

Copy

Share Video

.

Copy